$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-035/16
출원번호 US-0946421 (1992-11-06)
우선권정보 EP-1933892 (1991-03-06)
국제출원번호 PCT/EP92/00480 (1992-03-04)
§371/§102 date 19921106 (19921106)
국제공개번호 WO-9215683 (1992-09-17)
발명자 / 주소
  • Bendig Mary M. (London GBX) Kettleborough Catherine A. (Herts GBX) Saldanha Jose (Middlesex GBX)
출원인 / 주소
  • Merck Patent Gesellschaft Mit Beschrankter Haftung (Darmstadt DEX 03)
인용정보 피인용 횟수 : 195  인용 특허 : 0

초록

Humanized and chimeric anti-epidermal growth factor receptor (anti-EGF-R) monoclonal antibodies are disclosed, comprising an artificial modified consensus sequence for the heavy chain of the framework region of the variable region of a human immunoglobulin. Corresponding humanized and chimeric monoc

대표청구항

A humanized antibody, comprising a variable region and a constant region, wherein the hypervariable region of the light chain CDRs has the following amino acid sequences: ________________________________ - CDR-1 Ser-Ala-Ser-Ser-Ser-Val-Thr-Tyr-Met-Tyr (SEQ ID NO:1), CDR-2 Asp-Thr-Ser-Asn-Leu-Ala-Ser

이 특허를 인용한 특허 (195)

  1. Clarke, Adam; Pollard, Matthew; Doyle, Anthony Gerard; Behrens, Collette; Yamagishi, Tetsuo; Wilson, Jr., David S.; Pogue, Sarah L.; Taura, Tetsuya, Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B.
  2. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  3. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  4. Gu, Jijie; Ambrosi, Dominic J.; Lappe, Susan E.; Li, Yingchun; Hickson, Jonathan A.; Haasch, Deanna L.; Gupta, Supriya; Chari, Ravi; Zamiri, Camellia; Naumovski, Louie; Cao, Xianhua, Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof.
  5. Rabuka, David; Albers, Aaron Edward; Barfield, Robyn M.; deHart, Gregory W.; Drake, Penelope M.; Kudirka, Romas Alvydas; Garofalo, Albert W.; McFarland, Jesse M., Anti-HER2 antibody-maytansine conjugates and methods of use thereof.
  6. Schreiber, Taylor H.; Hutchins, Jeff T., Anti-TNFRSF25 antibodies.
  7. Baca,Manuel; Wells,James A.; Presta,Leonard G.; Lowman,Henry B.; Chen,Yvonne Man yee, Anti-VEGF antibodies.
  8. Gu, Jijie; Bowley, Diana; Eaton, Lucia; Dong, Feng; Benatuil, Lorenzo; Ghayur, Tariq; Chari, Ravi; Rieser, Matthew; Clabbers, Anca, Antibodies against platelet-derived growth factor (PDGF).
  9. Wu, Yan; Hicklin, Danny J.; Bohlen, Peter, Antibodies against vascular endothelial growth factor receptor-1.
  10. Krumlauf, Robb; Ellies, Debra, Antibodies that specifcally bind Sost and Wise peptides.
  11. Dahiyat, Bassil I.; Lazar, Gregory A.; Bernett, Matthew J., Antibodies with modified isoelectric points.
  12. Lazar, Gregory A.; Dahiyat, Bassil I.; Bernett, Matthew J., Antibodies with modified isoelectric points.
  13. Barske, Carmen; Mir, Anis Khusro; Oertle, Thomas; Schnell, Lisa; Schwab, Martin E.; Vitaliti, Alessandra; Zurini, Mauro, Antibody (11C7) anti Nogo-A and its pharmaceutical use.
  14. Wittrup, Karl Dane; Spangler, Jamie B.; Epstein, Benjamin E.; Ross, Brian L., Antibody-based constructs directed against tyrosine kinase receptors.
  15. Uma{tilde under (n)}a, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  16. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  17. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  18. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  19. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  20. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  21. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  22. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  23. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  24. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  25. Umaña, Pablo; Mössner, Ekkehard, Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof.
  26. Yusibov, Vidadi; Mett, Vadim; Musiychuck, Konstantin; Skarjinskaia, Marina, Bacillus anthracis antigens, vaccine compositions, and related methods.
  27. Tickle, Simon Peter; Ladyman, Heather Margaret, Biological products.
  28. Ford, Shirin K.; Clark, Edwin A.; Huang, Xin, Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators.
  29. Chiu, Mark; Moores, Sheri; Neijssen, Joost; Parren, Paul; Schuurman, Janine, Bispecific EGFR/c-Met antibodies.
  30. Chiu, Mark; Moores, Sheri; Neijssen, Joost; Parren, Paul; Schuurman, Janine, Bispecific EGFR/c-Met antibodies.
  31. Chiu, Mark; Moores, Sheri; Neijssen, Joost; Parren, Paul; Schuurman, Janine, Bispecific EGFR/c-Met antibodies.
  32. Bernett, Matthew; Chu, Seung; Moore, Gregory; Desjarlais, John, Bispecific antibodies that bind to CD38 and CD3.
  33. Desai, Neil P.; Soon-Shiong, Patrick, Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane.
  34. Desai, Neil P.; Soon-Shiong, Patrick, Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane.
  35. Desai, Neil P.; Soon-Shiong, Patrick, Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane.
  36. Waugh, David John James; Wilson, Richard; Oladipo, Olabode, CXCR1 as a predictor of response to treatment with epidermal growth factor receptor therapeutic.
  37. Kunz, Arthur; Moran, Justin Keith; Rubino, Joseph Thomas; Jain, Neera; Vidunas, Eugene Joseph; Simpson, John McLean; Merchant, Nishith; DiJoseph, John Francis; Ruppen, Mark Edward; Damle, Nitin Krishnaji; Robbins, Paul David; Popplewell, Andrew George, Calicheamicin derivative-carrier conjugates.
  38. Kunz, Arthur; Moran, Justin Keith; Rubino, Joseph Thomas; Jain, Neera; Vidunas, Eugene Joseph; Simpson, John McLean; Merchant, Nishith; Dijoseph, John Francis; Ruppen, Mark Edward; Damle, Nitin Krishnaji; Robbins, Paul David; Popplewell, Andrew George, Calicheamicin derivative-carrier conjugates.
  39. Kunz, Arthur; Moran, Justin Keith; Rubino, Joseph Thomas; Jain, Neera; Vidunas, Eugene Joseph; Simpson, John McLean; Robbins, Paul David; Merchant, Nishith; DiJoseph, John Francis; Ruppen, Mark Edward; Damle, Nitin Krishnaji; Popplewell, Andrew George, Calicheamicin derivative-carrier conjugates.
  40. Kunz, Arthur; Moran, Justin Keith; Rubino, Joseph Thomas; Jain, Neera; Vidunas, Eugene Joseph; Simpson, John McLean; Robbins, Paul David; Merchant, Nishith; Dijoseph, John Francis; Ruppen, Mark Edward; Damle, Nitin Krishnaji; Popplewell, Andrew George, Calicheamicin derivative-carrier conjugates.
  41. Ramakrishnan,Vanitha; Powers,David; Johnson,Dale E.; Jeffry,Ursula; Bhaskar,Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  42. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  43. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  44. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  45. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  46. Ramakrishnan, Vanitha; Powers, David; Johnson, Dale E.; Jeffry, Ursula; Bhaskar, Vinay, Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis.
  47. Pogue, Sarah L.; Wilson, David S.; Doyle, Anthony Gerard; Behrens, Collette Jane, Combination of lenalidomide and polypeptide construct, and uses thereof.
  48. Gillies, Stephen D.; Azria, David; Larbouret, Christel; Pelegrin, André, Combination therapy using anti-EGFR and anti-HER2 antibodies.
  49. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  50. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  51. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  52. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  53. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  54. Desai, Neil P.; Soon-Shiong, Patrick, Combinations and modes of administration of therapeutic agents and combination therapy.
  55. Yusibov, Vidadi; Mett, Vadim; Hull, Anna, Compositions and methods for production of immunoglobulins.
  56. Lazar, Gregory A.; Moore, Gregory L., Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens.
  57. Kudirka, Romas Alvydas; Albers, Aaron Edward; Rabuka, David, Compounds and methods for producing a conjugate.
  58. Ghayur, Tariq; Gu, JiJie; Harris, Maria; Goodreau, Carrie; Saluja, Sonal, Dual specific binding proteins directed against IL-1 and/or IL-17.
  59. Hsieh, Chung-Ming; Ghayur, Tariq; Goodreau, Carrie L., Dual specific binding proteins directed against IL-13 and IL-17.
  60. Ghayur, Tariq; Gu, JiJie; Harris, Maria; Goodreau, Carrie; Saluja, Sonal, Dual specific binding proteins directed against IL-1β and/or IL-17.
  61. Wu, Chengbin; Ghayur, Tariq; Dixon, Richard W.; Salfeld, Jochen G., Dual variable domain immunoglobulin and uses thereof.
  62. Wu, Chengbin; Ghayur, Tariq; Dixon, Richard W.; Salfeld, Jochen G., Dual variable domain immunoglobulin and uses thereof.
  63. Ghayur, Tariq; Hahn, Alfred; Mueller, Bernhard, Dual variable domain immunoglobulins and uses thereof.
  64. Ghayur, Tariq; Isakson, Peter C.; Olson, Lisa M.; Wu, Chengbin; Hugunin, Margaret; Kamath, Rajesh V.; Cuff, Carolyn A.; Allen, Hamish J., Dual variable domain immunoglobulins and uses thereof.
  65. Ghayur, Tariq; Kamath, Rajesh V.; Liu, Junian; Honore, Marie P., Dual variable domain immunoglobulins and uses thereof.
  66. Ghayur, Tariq; Liu, Junjian; Isakson, Peter C., Dual variable domain immunoglobulins and uses thereof.
  67. Ghayur, Tariq; Liu, Junjian; Isakson, Peter C., Dual variable domain immunoglobulins and uses thereof.
  68. Ghayur, Tariq; Liu, Junjian; Manoj, Sharmila; Brophy, Susan E., Dual variable domain immunoglobulins and uses thereof.
  69. Ghayur, Tariq; Morgan-Lappe, Susan E.; Reilly, Edward B.; Kingsbury, Gillian A.; Phillips, Andrew; Wang, Jieyi; Bell, Randy L.; Norvell, Suzanne M.; Li, Yingchun; Liu, Junjian; Ying, Hua, Dual variable domain immunoglobulins and uses thereof.
  70. Ghayur, Tariq; Salfeld, Jochen G.; McPherson, Michael J., Dual variable domain immunoglobulins and uses thereof.
  71. Ghayur, Tariq; Salfeld, Jochen G.; McPherson, Michael J.; Harris, Maria C.; Liu, Junjian; Isakson, Peter C.; Gu, Jijie, Dual variable domain immunoglobulins and uses thereof.
  72. Setiady, Julianto; Park, Peter U.; Rui, Lingyun; Chittenden, Thomas; Payne, Gillian, EGFR-binding molecules and immunoconjugates thereof.
  73. Setiady, Julianto; Park, Peter U.; Rui, Lingyun; Chittenden, Thomas; Payne, Gillian, EGFR-binding molecules and immunoconjugates thereof.
  74. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan, FC variants with altered binding to FCRN.
  75. Lazar, Gregory Alan; Dang, Wei; Desjarlais, John R.; Karki, Sher Bahadur; Vafa, Omid; Hayes, Robert; Vielmetter, Jost, Fc variants.
  76. Lazar, Gregory Alan; Dang, Wei; Desjarlais, John; Karki, Sher Bahadur; Vafa, Omid; Hayes, Robert; Vielmetter, Jost, Fc variants having increased affinity for fcyrllc.
  77. Lazar, Gregory Alan, Fc variants that extend antibody half-life.
  78. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan, Fc variants with altered binding to FcRn.
  79. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan, Fc variants with altered binding to FcRn.
  80. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan, Fc variants with altered binding to FcRn.
  81. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan, Fc variants with altered binding to FcRn.
  82. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan, Fc variants with altered binding to FcRn.
  83. Chamberlain, Aaron Keith; Dahiyat, Bassil I.; Desjarlais, John Rudolph; Karki, Sher Bahadur; Lazar, Gregory Alan, Fc variants with altered binding to FcRn.
  84. Chamberlain, Aaron Keith; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan; Vielmetter, Jost; Yoder, Sean C., Fc variants with altered binding to FcRn.
  85. Chamberlain, Aaron Keith; Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan; Vielmetter, Jost; Yoder, Sean Christopher, Fc variants with altered binding to FcRn.
  86. Lazar, Gregory Alan; Dang, Wei; Desjarlais, John R.; Karki, Sher Bahadur; Vafa, Omid; Hayes, Robert, Fc variants with increased affinity for FcγRIIc.
  87. Diluzio, Willow; Nguyen, Phoung M.; Varga, Csanad M.; Palaniappan, Vaithianathan; Brown, Jason, Formulation for anti-α4β7 antibody.
  88. Diluzio, Willow; Truong, Nobel T.; Varga, Csanad M.; Palaniappan, Vaithianathan; Brown, Jason; Scholz, Catherine, Formulation for anti-α4β7 antibody.
  89. Fox, Irving H.; Scholz, Catherine, Formulation for anti-α4β7 antibody.
  90. Moore, Gregory; Desjarlais, John; Chu, Seung, Heterodimeric antibodies that bind CD3 and PSMA.
  91. Bernett, Matthew J.; Moore, Gregory; Desjarlais, John; Chu, Seung; Rashid, Rumana; Muchhal, Umesh; Lee, Sung-Hyung, Heterodimeric antibodies that bind CD3 and tumor antigens.
  92. Bernett, Matthew J.; Moore, Gregory; Desjarlais, John; Chu, Seung; Rashid, Rumana; Muchhal, Umesh; Lee, Sung-Hyung, Heterodimeric antibodies to CD3 X CD123.
  93. Bernett, Matthew J.; Moore, Gregory; Desjarlais, John; Chu, Seung; Rashid, Rumana; Muchhal, Umesh; Lee, Sung-Hyung, Heterodimeric antibodies to CD3 X CD20.
  94. Desjarlais, John R.; Moore, Gregory L.; Rashid, Rumana; Bernett, Matthew J., Heterodimeric proteins.
  95. Moore, Gregory; Bernett, Matthew; Desjarlais, John; Rashid, Rumana, Heterodimeric proteins.
  96. Moore, Gregory; Bernett, Matthew; Rashid, Rumana; Desjarlais, John, Heterodimeric proteins.
  97. Moore, Gregory; Rashid, Rumana; Desjarlais, John, Heterodimeric proteins.
  98. Hunig,Thomas, Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes.
  99. Schreiber, Taylor H., Human TNFRSF25 antibody.
  100. Liu, Meilin; Zhu, Zhenping, Human anti-epidermal growth factor receptor antibody.
  101. Zhu,Zhenping, Human antibodies specific to KDR and uses thereof.
  102. Jakobovits, Aya; Yang, Xiao-Dong; Gallo, Michael; Jia, Xiao-Chi, Human monoclonal antibodies to epidermal growth factor receptor.
  103. Jakobovits, Aya; Yang, Xiao-Dong; Gallo, Michael; Jia, Xiao-Chi, Human monoclonal antibodies to epidermal growth factor receptor.
  104. Meteo de Acosta del Rio, Christina Maria; Rodriguez, Rolando Perez; Frias, Ernesto Moreno, Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use.
  105. Carter Paul J. ; Presta Leonard G., Humanized antibodies and methods for making them.
  106. Ponath,Paul D.; Ringler,Douglas J.; Jones,S. Tarran; Newman,Walter; Saldanha,Jos?; Bendig,Mary M., Humanized immunoglobulin reactive with α4β7 integrin.
  107. Ponath,Paul D.; Ringler,Douglas J.; Jones,S. Tarran; Newman,Walter; Saldanha,Jos��; Bendig,Mary M., Humanized immunoglobulin reactive with α4β7 integrin.
  108. Yusibov, Vidadi; Mett, Vadim; Shoji, Yoko, Humanized neuraminidase antibody and methods of use thereof.
  109. Yusibov, Vidadi; Mett, Vadim; Shoji, Yoko, Humanized neuraminidase antibody and methods of use thereof.
  110. Kudirka, Romas Alvydas; Albers, Aaron Edward; Barfield, Robyn M.; Rabuka, David, Hydrazinyl-indole compounds and methods for producing a conjugate.
  111. Kudirka, Romas Alvydas; Albers, Aaron Edward; Barfield, Robyn M.; Rabuka, David, Hydrazinyl-indole compounds and methods for producing a conjugate.
  112. Rabuka, David; Albers, Aaron Edward; Kudirka, Romas Alvydas; Garofalo, Albert W., Hydrazinyl-pyrrolo compounds and methods for producing a conjugate.
  113. Lacy, Susan E.; Benatuil, Lorenzo; Chhaya, Meha; Fung, Emma; Miller, Renee; Chari, Ravi; Heighton, Sarah J.; Bixby, Jacqueline G., IL-1 binding proteins.
  114. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  115. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  116. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  117. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  118. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  119. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-1 binding proteins.
  120. Hsieh, Chung-Ming; Hugunin, Margaret; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca, IL-17 binding proteins.
  121. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  122. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  123. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  124. Hsieh, Chung-Ming; Hugunin, Margaret; Murtaza, Anwar; McRae, Bradford L.; Kutskova, Yuliya; Memmott, John E.; Perez, Jennifer M.; Zhong, Suju; Tarcsa, Edit; Clabbers, Anca; Wallace, Craig; Bryant, Shaughn H.; Leddy, Mary R., IL-17 binding proteins.
  125. Wu, Chengbin; Ambrosi, Dominic J.; Hsieh, Chung-ming; Ghayur, Tariq, IL-I binding proteins.
  126. Lazar, Gregory A.; Dahiyat, Bassil I.; Dang, Wei; Karki, Sher Bahadur; Vafa, Omid, Immunoglobulin insertions, deletions and substitutions.
  127. Yusibov, Vidadi; Mett, Vadim; Musiychuck, Konstantin, Influenza antigens, vaccine compositions, and related methods.
  128. Yusibov, Vidadi; Mett, Vadim; Chichester, Jessica; Goldschmidt, Lauren, Influenza hemagglutinin antibodies, compositions and related methods.
  129. Yusibov, Vidadi; Mett, Vadim; Chichester, Jessica; Goldschmidt, Lauren, Influenza hemagglutinin antibodies, compositions and related methods.
  130. Benatuil, Lorenzo; Deng, Kangwen; Hanzatian, Denise Karaoglu; Argiriadi, Maria A., LRP-8 binding dual variable domain immunoglobulin proteins.
  131. Tomlinson, Ian; Jespers, Laurent; Clube, Jasper; Holt, Lucy J.; Schon, Oliver, Ligand.
  132. Ignatovich, Olga; Holmes, Steve; Beckmann, Roland; de Wildt, Rudolf M. T., Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor.
  133. Carter, Paul J.; Presta, Leonard G., Method for making humanized antibodies.
  134. Carter, Paul J.; Presta, Leonard G., Method for making humanized antibodies.
  135. Carter, Paul J.; Presta, Leonard G., Method for making humanized antibodies.
  136. Carter, Paul J.; Presta, Leonard G., Method for making humanized antibodies.
  137. Paul J. Carter ; Leonard G. Presta, Method for making humanized antibodies.
  138. Setiady, Julianto; Park, Peter U.; Chittenden, Thomas, Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate.
  139. Dong, Haidong; Kwon, Eugene D.; Markovic, Svetomir N.; Krco, Christopher J., Methods and materials for treating cancer.
  140. Dong, Haidong; Harrington, Susan M.; Kwon, Eugene D.; Krco, Christopher J.; Liu, Xin, Methods for treating cancer in patients with elevated levels of BIM.
  141. Ellies, Debra L., Methods of altering bone growth by administration of sost or wise antagonist or agonist.
  142. Ellies, Debra L., Methods of altering bone growth by administration of sost or wise antagonist or agonist.
  143. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treating cancer.
  144. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treating cancer.
  145. Fox, Irving H.; Scholz, Catherine, Methods of treating ulcerative colitis.
  146. Fox, Irving H.; Scholz, Catherine, Methods of treating ulcerative colitis.
  147. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treatment of pancreatic cancer.
  148. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treatment of pancreatic cancer.
  149. Desai, Neil P.; Soon-Shiong, Patrick, Methods of treatment of pancreatic cancer.
  150. Pedersen, Mikkel Wandahl; Kragh, Michael; Hey, Adam S.; Jacobsen, Helle, Methods using recombinant anti-epidermal growth factor receptor antibody compositions.
  151. Desjarlais, John R.; Karki, Sher Bahadur; Lazar, Gregory Alan; Richards, John O.; Moore, Gregory L.; Carmichael, David F., Modified FC molecules.
  152. Carr,Francis J.; Carter,Graham; Jones,Tim; Williams,Stephen; Hamilton,Anita, Modified anti-EGFR antibodies with reduced immunogenicity.
  153. Bernett, Matthew; Chu, Seung; Wickramarachichi, Dilki; Desjarlais, John, Modulation of T cells with bispecific antibodies and FC fusions.
  154. Taylor, Alexander H., Monoclonal antibodies with reduced immunogenicity.
  155. Johns, Terrance Grant; Stockert, Elizabeth; Old, Lloyd J.; Scott, Andrew M.; Rayzman, Veronika M., Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof.
  156. Briskin, Michael J., Mucosal vascular addressins and uses thereof.
  157. Setiady, Julianto; Singh, Rajeeva; Park, Peter U.; Rui, Lingyun; Chittenden, Thomas, Non-antagonistic EGFR-binding molecules and immunoconjugates thereof.
  158. Lazar, Gregory Alan; Chirino, Arthur J.; Dang, Wei; Desjarlais, John R.; Doberstein, Stephen K.; Hayes, Robert J.; Karki, Sher Bahadur; Vafa, Omid, Optimized Fc variants and methods for their generation.
  159. Lazar, Gregory Alan; Chirino, Arthur J.; Dang, Wei; Desjarlais, John R.; Doberstein, Stephen Kohl; Hayes, Robert J.; Karki, Sher Bahadur; Vafa, Omid, Optimized Fc variants and methods for their generation.
  160. Moore, Gregory; Bernett, Matthew; Rashid, Rumana; Desjarlais, John, Optimized antibody variable regions.
  161. Kreysch, Hans Georg; Schmidt, Juergen, Pharmaceutical compositions directed to Erb-B1 receptors.
  162. Bertozzi, Carolyn; Agarwal, Paresh; Sletten, Ellen M., Pictet-Spengler ligation for protein chemical modification.
  163. Steward, Michael; Pupecka, Malgorzata; Tomlinson, Ian; Enever, Carolyn; Jespers, Laurent; Batuwangala, Thil Dinuk, Polypeptides, antibody variable domains and antagonists.
  164. Nadel, Jay A.; Takeyama, Kiyoshi, Preventing airway mucus production by administration of EGF-R antagonists.
  165. Wolfgang Strittmatter DE; Siegfried Matzku DE; Dieter Riesenberg DE; Uwe Horn DE; Uwe Knupeer DE; Marian Kujau DE; Rolf Wenderoth DE; Andreas Pluckthun CH; Anke Krebber CH, Process for the preparation of recombinant proteins in E. coli by high cell density fermentation.
  166. Yusibov, Vidadi; Mett, Vadim; Rabindran, Shailaja; Shamloul, Moneim; Ensley, Burt, Production of foreign nucleic acids and polypeptides in sprout systems.
  167. Ensley, Burt D.; Yusibov, Vidadi, Production of pharmaceutically active proteins in sprouted seedlings.
  168. Ghayur, Tariq; Gu, Jijie; Isakson, Peter C., Prostaglandin E2 dual variable domain immunoglobulins and uses thereof.
  169. Moore, Gregory L.; Desjarlais, John; Bernett, Matthew, Rapid clearance of antigen complexes using novel antibodies.
  170. Pedersen, Mikkel Wandahl; Steinaa, Lucilla; Jensen, Allan; Koefoed, Klaus; Meijer, Per-Johan; Carlsson, Robert; Pyke, Charles; Nielsen, Lars Sogaard, Recombinant anti-epidermal growth factor receptor antibody compositions.
  171. Yusibov, Vidadi; Mett, Vadim; Musiychuk, Konstantin, Recombinant carrier molecule for expression, delivery and purification of target polypeptides.
  172. Yusibov, Vidadi; Mett, Vadim; Musiychuk, Konstantin, Recombinant carrier molecule for expression, delivery and purification of target polypeptides.
  173. Yusibov, Vidadi; Mett, Vadim; Musiychuk, Konstantin, Recombinant carrier molecule for expression, delivery and purification of target polypeptides.
  174. Srivastava,Arun; Qing,Keyun; Wang,Xu Shan; Ponnazhagan,Selvarangan; Bajpai,Anil, Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.
  175. Old, Lloyd J.; Ritter, Gerd; Jungbluth, Achim; Stockert, Elisabeth; Cavenee, Webster K., Specific binding proteins and uses thereof.
  176. Old, Lloyd J.; Ritter, Gerd; Jungbluth, Achim; Stockert, Elisabeth; Cavenee, Webster K., Specific binding proteins and uses thereof.
  177. Ritter, Gerd; Murray, Anne; Mark, George; Renner, Christoph, Specific binding proteins and uses thereof.
  178. Fedorkin, Oleg; Rabindran, Shailaja; Yusibov, Vidadi, System for expression of genes in plants.
  179. Fedorkin, Oleg; Rabindran, Shailaja; Yusibov, Vidadi, System for expression of genes in plants.
  180. Fedorkin, Oleg; Rabindran, Shailaja; Yusibov, Vidadi, System for expression of genes in plants.
  181. Fedorkin, Oleg; Rabindran, Shailaja; Yusibov, Vidadi, System for expression of genes in plants.
  182. Fedorkin, Oleg; Rabindran, Shailaja; Yusibov, Vidadi, System for expression of genes in plants.
  183. Yusibov, Vidadi; Skarjinskaia, Marina, Systems and methods for clonal expression in plants.
  184. Yashwant M. Deo ; Joel Goldstein ; Robert Graziano ; Chezian Somasundaram, Therapeutic compounds comprised of anti-Fc receptor antibodies.
  185. Yashwant M. Deo ; Joel Goldstein ; Robert Graziano ; Chezian Somasundaram, Therapeutic compounds comprised of anti-Fc receptor antibodies.
  186. Rose,William C., Therapeutic synergy of anti-cancer compounds.
  187. Jakobovits, Aya; Kucherlapati, Raju; Klapholz, Sue; Mendez, Michael J.; Green, Larry, Transgenic mammals having human IG loci including plural Vand Vregions and antibodies produced therefrom.
  188. Jakobovits, Aya; Kucherlapati, Raju; Klapholz, Susan; Mendez, Michael J; Green, Larry, Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefrom.
  189. Johns, Terrance Grant; Cavenee, Webster; Furnari, Frank; Scott, Andrew, Treatment method using EGFR antibodies and SRC inhibitors and related formulations.
  190. Ringler, Douglas J.; Picarella, Dominic; Newman, Walter, Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam.
  191. Knapp, Elisabeth; Yusibov, Vidadi, Trypanosoma antigens, vaccine compositions, and related methods.
  192. Wong, Kwok-Kin, Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease.
  193. Ramakrishnan, Vanitha; Bhaskar, Vinay; Ho, Sun; Murray, Richard; Law, Debbie, Use of anti-α5β1 antibodies to inhibit cancer cell proliferation.
  194. Yusibov, Vidadi; Mett, Vadim; Musiychuk, Konstantin, Yersinia pestis antigens, vaccine compositions, and related methods.
  195. Yusibov, Vidadi; Mett, Vadim; Musiychuk, Konstantin, Yersinia pestis antigens, vaccine compositions, and related methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로